Engineering collagen-binding serum albumin (CBD-SA) as a drug conjugate carrier for cancer therapy
MedicalXpress,
Synthesis and characterization of Dox-CBD-SA. (A) Schematic of CBD-SA mediated drug delivery.
Synthesis and characterization of Dox-CBD-SA. (A) Schematic of CBD-SA mediated drug delivery.
© JOVAN VAITANOVSKI/SHUTTERSTOCK.COM A cancer diagnosis often results in any number of relatively nonspecific treatments, such…
Preliminary attempt in humans generates robust immune response.
Peptides containing tumor somatic mutations are potentially immunogenic if presented on major histocompatibility complex class…
by ecancer reporter Janet Fricker Five studies reveal a growing list of cancers responding to checkpoint blockade and start to…
1. Following checkpoint blockade therapy (CBT) in a mouse sarcoma model, two dominant tumor-specific mutant antigen (TSMA…
News report Drugs that allow the immune system to recognise cancer and attack it are continuing to produce "exciting" results…
Human tumours typically harbour a remarkable number of somatic mutations. If presented on major histocompatibility complex…
Hasta hoy, la inmunoterapia oncológica, que reactiva las defensas del organismo para aniquilar el cáncer, solo había mostrado…
Molecular signatures hint at who will benefit from next-generation cancer drugs.